Inlyta Prices, Coupons and Patient Assistance Programs
Inlyta (axitinib) is a member of the multikinase inhibitors drug class and is commonly used for Renal Cell Carcinoma.
Inlyta Prices
This Inlyta price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Inlyta oral tablet 1 mg is around $16,543 for a supply of 180 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Inlyta is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Inlyta availability.
Oral Tablet
| Quantity | Per unit | Price |
|---|---|---|
| 180 | $91.90 | $16,542.88 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
| Quantity | Per unit | Price |
|---|---|---|
| 60 | $275.71 | $16,542.88 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
Print NowThe free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Inlyta Coupons and Rebates
Inlyta offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Inlyta Pfizer Oncology Together Co-Pay Savings Program: Eligible commercially insured patients may pay as little as $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 877-744-5675.
| Applies to: | Inlyta |
| Number of uses: | 12 times within calendar year |
| Expires | December 31, 2021 |
Patient Assistance Programs for Inlyta
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Inlyta (axitinib) Tablet
Provider: Pfizer Savings Program
Elligibility requirements:
- Must be uninsured
- Varies
- Not specified
- Must be residing in the US or US territory
- This program provides uninsured patients with savings on their prescriptions at the pharmacy. Pfizer also has programs that provide eligible patients with insurance support, copay assistance, and medicines for free. Contact Pfizer RxPathways for details (844-989-7284)
Applicable drugs:
- Inlyta (axitinib) Tablet
Provider: Pfizer Oncology Together
Elligibility requirements:
- Contact program for details.
- Not disclosed
- Varies
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
- Inlyta (axitinib) Tablet
More about Inlyta (axitinib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: multikinase inhibitors
- FDA Approval History
